Literature DB >> 16415099

The proliferative response of CD4 T cells to steady-state CD8+ dendritic cells is restricted by post-activation death.

Alexandra Rizzitelli1, Edwin Hawkins, Hilary Todd, Philip D Hodgkin, Ken Shortman.   

Abstract

CD8(+) splenic dendritic cells (DCs) from steady-state mice are less effective than the CD8(-) DC subset in their capacity to stimulate CD4 T cell proliferation in culture. However, we found that the two DC subtypes were equally potent at activating CD4 T cells, based on up-regulation of CD69 and CD25 expression. Also, we found no difference in the rate of T cell death prior to entry into the first division. We then tracked carboxyfluorescein diacetate succinimidyl ester-labeled T cells and employed a quantitative model to assess in detail the CD4 T cell expansion process in response to stimulation with CD8(+) or with CD8(-) DCs. The time required for most T cells to replicate their DNA prior to the first division was similar in both DC cultures. However, progression of the CD4 T cell population through subsequent divisions was reduced in CD8(+) DCs compared with CD8(-) DC culture. This was associated with an increased loss of viable T cells at each division. Post-activation, division-associated T cell death is therefore a major factor in the reduced response of CD4 T cells to CD8(+) DCs.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16415099     DOI: 10.1093/intimm/dxh382

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  7 in total

1.  RNF41 regulates the damage recognition receptor Clec9A and antigen cross-presentation in mouse dendritic cells.

Authors:  Kirsteen M Tullett; Peck Szee Tan; Hae-Young Park; Ralf B Schittenhelm; Nicole Michael; Rong Li; Antonia N Policheni; Emily Gruber; Cheng Huang; Alex J Fulcher; Jillian C Danne; Peter E Czabotar; Linda M Wakim; Justine D Mintern; Georg Ramm; Kristen J Radford; Irina Caminschi; Meredith O'Keeffe; Jose A Villadangos; Mark D Wright; Marnie E Blewitt; William R Heath; Ken Shortman; Anthony W Purcell; Nicos A Nicola; Jian-Guo Zhang; Mireille H Lahoud
Journal:  Elife       Date:  2020-12-02       Impact factor: 8.140

Review 2.  Dendritic cell control of tolerogenic responses.

Authors:  Santhakumar Manicassamy; Bali Pulendran
Journal:  Immunol Rev       Date:  2011-05       Impact factor: 12.988

3.  Rabbit polyclonal mouse antithymocyte globulin administration alters dendritic cell profile and function in NOD mice to suppress diabetogenic responses.

Authors:  Yanfei Huang; Matthew Parker; Changqing Xia; Ruihua Peng; Clive Wasserfall; Tracy Clarke; Lizhen Wu; Tayseer Chowdhry; Martha Campbell-Thompson; John Williams; Michael Clare-Salzler; Mark A Atkinson; Karl L Womer
Journal:  J Immunol       Date:  2009-04-15       Impact factor: 5.422

4.  Systemic IFN-alpha drives kidney nephritis in B6.Sle123 mice.

Authors:  Anna-Marie Fairhurst; Alexis Mathian; John E Connolly; Andrew Wang; Hillery F Gray; Tiffany A George; Christopher D Boudreaux; Xin J Zhou; Quan-Zhen Li; Sophie Koutouzov; Jacques Banchereau; Edward K Wakeland
Journal:  Eur J Immunol       Date:  2008-07       Impact factor: 5.532

5.  Specificity, Privacy, and Degeneracy in the CD4 T Cell Receptor Repertoire Following Immunization.

Authors:  Yuxin Sun; Katharine Best; Mattia Cinelli; James M Heather; Shlomit Reich-Zeliger; Eric Shifrut; Nir Friedman; John Shawe-Taylor; Benny Chain
Journal:  Front Immunol       Date:  2017-04-13       Impact factor: 7.561

6.  Regulatory T Cells Suppress Effector T Cell Proliferation by Limiting Division Destiny.

Authors:  Mark R Dowling; Andrey Kan; Susanne Heinzel; Julia M Marchingo; Philip D Hodgkin; Edwin D Hawkins
Journal:  Front Immunol       Date:  2018-10-30       Impact factor: 7.561

Review 7.  New Therapeutic Approaches for Conjunctival Melanoma-What We Know So Far and Where Therapy Is Potentially Heading: Focus on Lymphatic Vessels and Dendritic Cells.

Authors:  Jennifer Peil; Felix Bock; Friedemann Kiefer; Rebecca Schmidt; Ludwig M Heindl; Claus Cursiefen; Simona L Schlereth
Journal:  Int J Mol Sci       Date:  2022-01-27       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.